Rapid histologic assessment of fresh prostate biopsies may reduce patient anxiety, aid in biopsy sampling, and enable specimen triaging for molecular/genomic analyses and research that could benefit ...

Patients who had undergone radical prostatectomy for prostatic adenocarcinoma from three university medical centers in The Netherlands between 2000 and 2017 were included in this study; 854 patients ...

A pathology test that applies artificial intelligence (AI) to characterize tissue samples can accurately predict clinically significant prostate cancer disease progression following surgery, according ...

Predicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostatectomy or radiation therapy. Yet, prostate cancer ...

MRI reports and biopsy pathology reports were extracted from a cohort of 1,360,866 patients with PCa in the VA Cancer Registry System or the VA Corporate Data Warehouse, with 155,570 patients having ...

BOSTON, Oct. 3 -- The Gleason score of 7 for localized prostate cancer may be a moving prognostic target, according to investigators here. By relying on the two most prevalent biopsy patterns, and ...

The modern approach to AS was first described in 1995, and numerous programs have now reported follow-up outcomes at 5 years and beyond. 8 In Toronto, Klotz et al 5 initiated a program of AS aimed at ...

President Biden's diagnosis with an aggressive prostate cancer, highlighted the importance of the Gleason scoring system in determining treatment. A high Gleason score indicates a greater risk of ...

Dr. Donald F. Gleason, who devised the Gleason score, which has been used to help determine the aggressiveness of prostate cancer in millions of men, died on Dec. 28 in Edina, Minn. He was 88. The ...

(New York - October 2, 2018) A pathology test that applies artificial intelligence (AI) to characterize tissue samples can accurately predict clinically significant prostate cancer disease progression ...